Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

Summary

Evotec and Plectonic announced a research collaboration to explore T-cell-engaging bispecifics for solid tumors, combining Evotec's BiTco costimulatory CD2 platform with Plectonic's LOGIBODY® technology to enhance T cell activation.